Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gardasil for prevention of cervical precancer in women with HIV on antiretroviral therapy
PACTR202003634132762Phase 3Not yet recruiting
- Start
- Apr 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of qHPV vaccine in human papillomavirus infection, cervical intraepithelial neoplasia (CIN) and Cervical Cancer (CC) (2 arms). Planned start Apr 2020; status: not yet recruiting.
02
Drugs
qHPV vaccine
03
Conditions
human papillomavirus infectioncervical intraepithelial neoplasia (CIN)Cervical Cancer (CC)
Beyond the preview
Go deeper on PACTR202003634132762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202003634132762.